Alliance Pharma and Drug Development Solutions, Ltd. (acquired in 2022), a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, are now operating under the new name Resolian — fully integrating the companies into one organisation.

Proven expertise.
Worldwide access.

Our bioanalytical services CRO supports you from early discovery to late phase clinical trials. 

We routinely solve difficult method development challenges and, as your development progresses from discovery through to GLP preclinical and to GCP clinical trials, we have the capacity, rapid turnaround and logistics needed to support the largest, most complex protocols.

From our UK-based cGMP labs, our scientists partner with you to provide a consultative, flexible and dependable solution for the development, validation, and application of testing methods.